These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 26792232)

  • 1. DNA methylation signatures of mood stabilizers and antipsychotics in bipolar disorder.
    Houtepen LC; van Bergen AH; Vinkers CH; Boks MP
    Epigenomics; 2016 Feb; 8(2):197-208. PubMed ID: 26792232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of quetiapine on DNA methylation in neuroblastoma cells.
    Sugawara H; Bundo M; Asai T; Sunaga F; Ueda J; Ishigooka J; Kasai K; Kato T; Iwamoto K
    Prog Neuropsychopharmacol Biol Psychiatry; 2015 Jan; 56():117-21. PubMed ID: 25194461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Protein Kinase B (AKT) DNA Hypermethylation with Maintenance Atypical Antipsychotic Treatment in Patients with Bipolar Disorder.
    Burghardt KJ; Seyoum B; Dass SE; Sanders E; Mallisho A; Yi Z
    Pharmacotherapy; 2018 Apr; 38(4):428-435. PubMed ID: 29484683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mood stabilization and the role of antipsychotics.
    Yatham LN
    Int Clin Psychopharmacol; 2002 Aug; 17 Suppl 3():S21-7. PubMed ID: 12570068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding the molecular mechanisms underlying mood stabilizer treatments in bipolar disorder: Potential involvement of epigenetics.
    Pisanu C; Papadima EM; Del Zompo M; Squassina A
    Neurosci Lett; 2018 Mar; 669():24-31. PubMed ID: 27343410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of quetiapine plus mood stabilizers compared with mood stabilizers alone in the maintenance therapy of bipolar I disorder: results of a Markov model analysis.
    Fajutrao L; Paulsson B; Liu S; Locklear J
    Clin Ther; 2009 Jun; 31 Pt 1():1456-68. PubMed ID: 19698903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atypical antipsychotic augmentation of mood stabilizer therapy in bipolar disorder.
    Bowden CL
    J Clin Psychiatry; 2005; 66 Suppl 3():12-9. PubMed ID: 15762830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lithium-responsive genes and gene networks in bipolar disorder patient-derived lymphoblastoid cell lines.
    Breen MS; White CH; Shekhtman T; Lin K; Looney D; Woelk CH; Kelsoe JR
    Pharmacogenomics J; 2016 Oct; 16(5):446-53. PubMed ID: 27401222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA methylation, insulin resistance and second-generation antipsychotics in bipolar disorder.
    Burghardt KJ; Goodrich JM; Dolinoy DC; Ellingrod VL
    Epigenomics; 2015; 7(3):343-52. PubMed ID: 26077424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term use of atypical antipsychotics in bipolar disorder.
    Ehret MJ; Levin GM
    Pharmacotherapy; 2006 Aug; 26(8):1134-47. PubMed ID: 16863489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mood stabilizers and atypical antipsychotics: bimodal treatments for bipolar disorder.
    Ketter TA; Nasrallah HA; Fagiolini A
    Psychopharmacol Bull; 2006; 39(1):120-46. PubMed ID: 17065977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of life assessment in patients with bipolar disorder treated with olanzapine added to lithium or valproic acid.
    Namjoshi MA; Risser R; Shi L; Tohen M; Breier A
    J Affect Disord; 2004 Sep; 81(3):223-9. PubMed ID: 15337326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA methylation and expression of KCNQ3 in bipolar disorder.
    Kaminsky Z; Jones I; Verma R; Saleh L; Trivedi H; Guintivano J; Akman R; Zandi P; Lee RS; Potash JB
    Bipolar Disord; 2015 Mar; 17(2):150-9. PubMed ID: 25041603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetics of psychoactive drugs.
    Boyadjieva N; Varadinova M
    J Pharm Pharmacol; 2012 Oct; 64(10):1349-58. PubMed ID: 22943166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetics in bipolar disorder: a critical review of the literature.
    Legrand A; Iftimovici A; Khayachi A; Chaumette B
    Psychiatr Genet; 2021 Feb; 31(1):1-12. PubMed ID: 33290382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antipsychotic drugs, mood stabilizers, and risk of pneumonia in bipolar disorder: a nationwide case-control study.
    Yang SY; Liao YT; Liu HC; Chen WJ; Chen CC; Kuo CJ
    J Clin Psychiatry; 2013 Jan; 74(1):e79-86. PubMed ID: 23419234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome-wide DNA methylome variation in two genetically distinct chicken lines using MethylC-seq.
    Li J; Li R; Wang Y; Hu X; Zhao Y; Li L; Feng C; Gu X; Liang F; Lamont SJ; Hu S; Zhou H; Li N
    BMC Genomics; 2015 Oct; 16():851. PubMed ID: 26497311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rationale for using lithium in combination with other mood stabilizers in the management of bipolar disorder.
    Goodwin FK
    J Clin Psychiatry; 2003; 64 Suppl 5():18-24. PubMed ID: 12720480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Search for common targets of lithium and valproic acid identifies novel epigenetic effects of lithium on the rat leptin receptor gene.
    Lee RS; Pirooznia M; Guintivano J; Ly M; Ewald ER; Tamashiro KL; Gould TD; Moran TH; Potash JB
    Transl Psychiatry; 2015 Jul; 5(7):e600. PubMed ID: 26171981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.